Enable JavaScript to visit this website.

NOW APPROVED

Selected Important Safety Information

Adverse Reactions

In studies in patients with ATTR-CM, the frequency of adverse events in patients treated with VYNDAQEL was similar to placebo.

Specific Populations

Pregnancy: Based on findings from animal studies, VYNDAQEL may cause fetal harm when administered to a pregnant woman.

Please see full safety information below.

INDICATION

IMPORTANT SAFETY INFORMATION